BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+30.37%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$12B
AUM Growth
+$12B
(+23%)
Cap. Flow
-$219M
Cap. Flow
% of AUM
-1.82%
Top 10 Holdings %
Top 10 Hldgs %
76.74%
Holding
140
New
18
Increased
23
Reduced
51
Closed
10
Top Buys
| 1 |
NVTA
Invitae Corporation
NVTA
|
$110M |
| 2 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$103M |
| 3 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$97.5M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$60.6M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$35.9M |
Top Sells
| 1 |
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
|
$653M |
| 2 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$73M |
| 3 |
Vanda Pharmaceuticals
VNDA
|
$25.3M |
| 4 |
PCYC
PHARMACYCLICS INC
PCYC
|
$22.9M |
| 5 |
Xoma
XOMA
|
$8.06M |
Sector Composition
| 1 | Healthcare | 40.26% |